BioSpace News Archive

GADOPICLENOL: ANOTHER MILESTONE ACHIEVED

Bracco is very excited about the Priority Review granted by the U.S. Food and Drug Administration (FDA) to the New Drug Application (NDA) of the investigational high-relaxivity, macrocyclic gadolinium-based contrast agent (GBCA) Gadopiclenol.

March 31, 2022
·
3 min read
Pharm Country

Zoetis to Host Webcast and Conference Call on First Quarter 2022 Financial Results

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 5, 2022.

March 31, 2022
·
1 min read
Business

Tenax Therapeutics Reports Fiscal Year 2021 Results and Provides Business Update

Tenax Therapeutics, Inc. today reported financial results for the year ended December 31, 2021 and provided a business update.

March 31, 2022
·
10 min read
Philips adds to its cardiology suite of solutions at ACC 2022 with innovations to help improve patient outcomes, experiences, and care pathway effectiveness

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced new additions to its innovative integrated portfolio of cardiology solutions at the American College of Cardiology’s Annual Scientific Session & Expo.

March 31, 2022
·
6 min read
Mapi Pharma to Present Posters on GA Depot for Treating Relapsing Forms of Multiple Sclerosis (MS) and Primary Progressive Forms of Multiple Sclerosis at the American Academy of Neurology (AAN) 2022 Annual Meeting

Mapi Pharma Ltd. announced that two posters featuring clinical data on GA Depot will be presented at the forthcoming American Academy of Neurology annual meeting, to take place in-person in Seattle, WA, April 2 to 7, and virtually April 24 to 26.

March 31, 2022
·
3 min read
Drug Development

Sorrento Reports FDA Clearance for the Commencement of a Phase 2/3 Study for Abivertinib in Treatment of Hospitalized Patients With Severe Pneumonia Due to COVID-19

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), announced today that the FDA has given clearance for Sorrento to commence the Phase 3 clinical trial of Abivertinib in severe COVID-19 patients (hospitalized patients with respiratory compromise requiring oxygen supplementation).

March 31, 2022
·
7 min read
BioCapital

Immunomic Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022

Immunomic Therapeutics, Inc. announced today that the company will be presenting two posters at the American Association for Cancer Research (AACR) Annual Meeting 2022 being held in New Orleans, Louisiana, from April 8-13.

March 31, 2022
·
3 min read
Genetown

EMD Serono Shares Advances in MS Portfolio with Key Efficacy and Safety Data at AAN 2022

EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced 13 abstracts from the Company’s multiple sclerosis portfolio will be presented at the 2022 American Academy of Neurology Annual Meeting, being held April 2-7.

March 31, 2022
·
21 min read
Business

Virpax Pharmaceuticals Reports 2021 Year-End Results

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the twelve months ended December 31, 2021, and other recent developments.

March 31, 2022
·
13 min read
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP

Gemina Laboratories Ltd. is pleased to provide recent development updates for its initial diagnostic test targeting the COVID-19 virus.

March 31, 2022
·
6 min read